Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers

NCT03643627 is registered in ClinicalTrials.gov with Syntimmune, Inc. as lead sponsor.

NCT NCT03643627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Lead sponsor
Syntimmune, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 17, 2016
Completion date
April 13, 2017
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy